New York – March 1st, 2019 – BRS & Co. (“BRS”), a New York-based private equity firm, announced that it has made an investment in Organika Health Products Inc. (“Organika” or the “Company”), a Canadian manufacturer of nutritional supplements. The financial terms of the transaction were not disclosed.
Since Organika’s founding in 1990, the Company has been dedicated to providing natural solutions that help people live healthier. Organika has developed a strong reputation for quality and innovation in the Canadian market. In recent years, Organika has introduced products in fast-growing categories such as collagen, bone broth, medicinal mushrooms, and other functional foods.
Aaron Chin, Organika’s CEO, said, “BRS’s track record of helping entrepreneur-owned businesses grow, combined with its past experience in nutritional supplements and the broader consumer products industry, will be invaluable in helping Organika achieve its long-term objectives.”
Rashad Rahman, Managing Director of BRS, said, “We are excited to partner with management and support the Company as it enters its next stage of growth. BRS has a long history of investing in the healthy living space, and is proud to support Organika’s mission of helping people live healthier.”
About BRS & Co.
BRS is a New York-based private equity investment firm with combined capital invested of $1.2 billion, focused on investing in lower middle market consumer goods and services businesses. Since 1996, BRS has purchased over 50 portfolio companies for aggregate consideration of over $6.9 billion. In addition, BRS portfolio companies have completed over 40 add-on acquisitions. For more information, please visit www.brs.com.